Cargando…

A fatal adverse effect of cefazolin administration: severe brain edema in a patient with multiple meningiomas

Cefazolin is commonly administered before surgery as a prophylactic antibiotic. Hypersensitivity to cefazolin is not uncommon, and the symptoms mostly include urticaria, skin reaction, diarrhea, vomiting, and transient neutropenia, which are rarely life threatening. We present a rare case of fatal c...

Descripción completa

Detalles Bibliográficos
Autores principales: Tribuddharat, Sirirat, Sathitkarnmanee, Thepakorn, Kitkhuandee, Amnat, Theerapongpakdee, Sunchai, Ngamsaengsirisup, Kriangsak, Chanthawong, Sarinya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755691/
https://www.ncbi.nlm.nih.gov/pubmed/26929668
http://dx.doi.org/10.2147/DHPS.S91514
_version_ 1782416226571517952
author Tribuddharat, Sirirat
Sathitkarnmanee, Thepakorn
Kitkhuandee, Amnat
Theerapongpakdee, Sunchai
Ngamsaengsirisup, Kriangsak
Chanthawong, Sarinya
author_facet Tribuddharat, Sirirat
Sathitkarnmanee, Thepakorn
Kitkhuandee, Amnat
Theerapongpakdee, Sunchai
Ngamsaengsirisup, Kriangsak
Chanthawong, Sarinya
author_sort Tribuddharat, Sirirat
collection PubMed
description Cefazolin is commonly administered before surgery as a prophylactic antibiotic. Hypersensitivity to cefazolin is not uncommon, and the symptoms mostly include urticaria, skin reaction, diarrhea, vomiting, and transient neutropenia, which are rarely life threatening. We present a rare case of fatal cefazolin hypersensitivity in a female who was diagnosed with multiple meningiomas and scheduled for craniotomy and tumor removal. Immediately after cefazolin IV administration, the patient developed acute hypertensive crisis, which resolved within 10 minutes after the treatment. This was followed by unexplained metabolic acidosis. The patient then developed severe brain edema 100 minutes later. The patient had facial edema when her face was exposed for the next 30 minutes. A computed tomography scan revealed global brain edema with herniation. She was admitted to the intensive care unit for symptomatic treatment and died 10 days after surgery from multiorgan failure. The serum IgE level was very high (734 IU/mL). Single-dose administration of cefazolin for surgical prophylaxis may lead to rare, fatal adverse reaction. The warning signs are sudden, unexplained metabolic acidosis, hypertensive crisis, tachycardia, and facial angioedema predominating with or without cutaneous symptoms like urticaria.
format Online
Article
Text
id pubmed-4755691
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-47556912016-02-29 A fatal adverse effect of cefazolin administration: severe brain edema in a patient with multiple meningiomas Tribuddharat, Sirirat Sathitkarnmanee, Thepakorn Kitkhuandee, Amnat Theerapongpakdee, Sunchai Ngamsaengsirisup, Kriangsak Chanthawong, Sarinya Drug Healthc Patient Saf Case Report Cefazolin is commonly administered before surgery as a prophylactic antibiotic. Hypersensitivity to cefazolin is not uncommon, and the symptoms mostly include urticaria, skin reaction, diarrhea, vomiting, and transient neutropenia, which are rarely life threatening. We present a rare case of fatal cefazolin hypersensitivity in a female who was diagnosed with multiple meningiomas and scheduled for craniotomy and tumor removal. Immediately after cefazolin IV administration, the patient developed acute hypertensive crisis, which resolved within 10 minutes after the treatment. This was followed by unexplained metabolic acidosis. The patient then developed severe brain edema 100 minutes later. The patient had facial edema when her face was exposed for the next 30 minutes. A computed tomography scan revealed global brain edema with herniation. She was admitted to the intensive care unit for symptomatic treatment and died 10 days after surgery from multiorgan failure. The serum IgE level was very high (734 IU/mL). Single-dose administration of cefazolin for surgical prophylaxis may lead to rare, fatal adverse reaction. The warning signs are sudden, unexplained metabolic acidosis, hypertensive crisis, tachycardia, and facial angioedema predominating with or without cutaneous symptoms like urticaria. Dove Medical Press 2016-02-09 /pmc/articles/PMC4755691/ /pubmed/26929668 http://dx.doi.org/10.2147/DHPS.S91514 Text en © 2016 Tribuddharat et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Case Report
Tribuddharat, Sirirat
Sathitkarnmanee, Thepakorn
Kitkhuandee, Amnat
Theerapongpakdee, Sunchai
Ngamsaengsirisup, Kriangsak
Chanthawong, Sarinya
A fatal adverse effect of cefazolin administration: severe brain edema in a patient with multiple meningiomas
title A fatal adverse effect of cefazolin administration: severe brain edema in a patient with multiple meningiomas
title_full A fatal adverse effect of cefazolin administration: severe brain edema in a patient with multiple meningiomas
title_fullStr A fatal adverse effect of cefazolin administration: severe brain edema in a patient with multiple meningiomas
title_full_unstemmed A fatal adverse effect of cefazolin administration: severe brain edema in a patient with multiple meningiomas
title_short A fatal adverse effect of cefazolin administration: severe brain edema in a patient with multiple meningiomas
title_sort fatal adverse effect of cefazolin administration: severe brain edema in a patient with multiple meningiomas
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755691/
https://www.ncbi.nlm.nih.gov/pubmed/26929668
http://dx.doi.org/10.2147/DHPS.S91514
work_keys_str_mv AT tribuddharatsirirat afataladverseeffectofcefazolinadministrationseverebrainedemainapatientwithmultiplemeningiomas
AT sathitkarnmaneethepakorn afataladverseeffectofcefazolinadministrationseverebrainedemainapatientwithmultiplemeningiomas
AT kitkhuandeeamnat afataladverseeffectofcefazolinadministrationseverebrainedemainapatientwithmultiplemeningiomas
AT theerapongpakdeesunchai afataladverseeffectofcefazolinadministrationseverebrainedemainapatientwithmultiplemeningiomas
AT ngamsaengsirisupkriangsak afataladverseeffectofcefazolinadministrationseverebrainedemainapatientwithmultiplemeningiomas
AT chanthawongsarinya afataladverseeffectofcefazolinadministrationseverebrainedemainapatientwithmultiplemeningiomas
AT tribuddharatsirirat fataladverseeffectofcefazolinadministrationseverebrainedemainapatientwithmultiplemeningiomas
AT sathitkarnmaneethepakorn fataladverseeffectofcefazolinadministrationseverebrainedemainapatientwithmultiplemeningiomas
AT kitkhuandeeamnat fataladverseeffectofcefazolinadministrationseverebrainedemainapatientwithmultiplemeningiomas
AT theerapongpakdeesunchai fataladverseeffectofcefazolinadministrationseverebrainedemainapatientwithmultiplemeningiomas
AT ngamsaengsirisupkriangsak fataladverseeffectofcefazolinadministrationseverebrainedemainapatientwithmultiplemeningiomas
AT chanthawongsarinya fataladverseeffectofcefazolinadministrationseverebrainedemainapatientwithmultiplemeningiomas